These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10342086)

  • 1. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.
    Roumen FJ; Dieben TO
    Contraception; 1999 Jan; 59(1):59-62. PubMed ID: 10342086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
    Milford C; Ramlal H; Mofokeng R; Rambally Greener L; Nel A; Smit J; Malherbe M
    BMC Public Health; 2024 May; 24(1):1458. PubMed ID: 38822304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system.
    Plagianos MG; Ramanadhan S; Merkatz RB; Brache V; Friedland BA; Haddad LB
    Am J Obstet Gynecol; 2024 May; 230(5):548.e1-548.e8. PubMed ID: 38295968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis.
    Griffin JB; Ridgeway K; Montgomery E; Torjesen K; Clark R; Peterson J; Baggaley R; van der Straten A
    PLoS One; 2019; 14(11):e0224898. PubMed ID: 31703094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.
    Schurmans C; De Baetselier I; Kestelyn E; Jespers V; Delvaux T; Agaba SK; van Loen H; Menten J; van de Wijgert J; Crucitti T;
    BMC Public Health; 2015 Apr; 15():348. PubMed ID: 25880636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda.
    Kestelyn E; Van Nuil JI; Umulisa MM; Umutoni G; Uwingabire A; Mwambarangwe L; Uwineza M; Agaba S; Crucitti T; van de Wijgert J; Delvaux T;
    PLoS One; 2018; 13(6):e0199096. PubMed ID: 29912906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between tampon use and choosing the contraceptive vaginal ring.
    Tepe M; Mestad R; Secura G; Allsworth JE; Madden T; Peipert JF
    Obstet Gynecol; 2010 Apr; 115(4):735-739. PubMed ID: 20308832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive.
    Mauck C; Thurman A; Jensen JT; Schreiber CA; Baker J; Hou MY; Chavoustie S; Dart C; Wu H; Zack N; Hatheway J; Friend D
    Contraception; 2024 Apr; 132():110373. PubMed ID: 38232942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019.
    McLellan-Lemal E; Deaton SR; Betts JE; Ondenge K; Mudhune V; O'Connor SM; Nyagol B; Thurman AR; Doncel GF; Allen SA; Heffron R; Mugo NR;
    Contemp Clin Trials; 2022 Nov; 122():106935. PubMed ID: 36162740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda.
    Kestelyn E; Van Nuil JI; Umulisa MM; Umutoni G; Uwingabire A; De Baetselier I; Uwineza M; Agaba S; Crucitti T; Delvaux T; van de Wijgert JHHM
    Front Glob Womens Health; 2024; 5():1278981. PubMed ID: 38680542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep.
    Davis S; Parthun K; Friend DR
    Contraception; 2024 May; 133():110387. PubMed ID: 38342425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.
    Hawley I; Song M; Scheckter R; McClure T; Piper J; Chen BA; Hoesley C; Liu AY; van der Straten A
    AIDS Res Hum Retroviruses; 2022 Apr; 38(4):313-326. PubMed ID: 34969254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of proteins from a modified vaginal ring device.
    Morrow RJ; Woolfson AD; Donnelly L; Curran R; Andrews G; Katinger D; Malcolm RK
    Eur J Pharm Biopharm; 2011 Jan; 77(1):3-10. PubMed ID: 21055465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensionally Printed Vaginal Rings: Perceptions of Women and Gynecologists in a Cross-Sectional Survey.
    Junqueira LA; Raposo FJ; Vitral GSF; Tabriz AG; Douroumis D; Raposo NRB; Brandão MAF
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolic Disease Provoked by Hormone-Eluting Vaginal Rings.
    Nanah A; Daw H; Abdelghaffar B
    Am J Ther; 2024 Jul-Aug 01; 31(4):e426-e430. PubMed ID: 37052675
    [No Abstract]   [Full Text] [Related]  

  • 16. Œdopsophia, or Noisy Expulsion of Gas from the Vagina.
    West J Med Surg; 1844 Jan; 1(1):78-79. PubMed ID: 38208222
    [No Abstract]   [Full Text] [Related]  

  • 17. Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings.
    Zhao X; Milford C; Smit J; Zulu B; Boyd P; Malcolm RK; Beksinska M
    AIDS Behav; 2022 Sep; 26(9):2954-2968. PubMed ID: 35294694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.
    Ridgeway K; Montgomery ET; Smith K; Torjesen K; van der Straten A; Achilles SL; Griffin JB
    Contraception; 2022 Feb; 106():16-33. PubMed ID: 34644609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-Release from High-Loaded Reservoir-Type Systems-A Case Study of Ethylene-Vinyl Acetate and Progesterone.
    Koutsamanis I; Paudel A; Nickisch K; Eggenreich K; Roblegg E; Eder S
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 32013050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel.
    Li J; Regev G; Patel SK; Patton D; Sweeney Y; Graebing P; Grab S; Wang L; Sant V; Rohan LC
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31861267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.